Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT05889793
Eligibility Criteria:
Inclusion Criteria:
* 30 years of age or older at time of randomization
* RT-PCR positive for SARS-CoV-2 infection within ≤ 10 days of the screening visit.
* In addition to confirmed RT-PCR, symptomatic Covid-19 patients with at least two or more symptoms within 7 days of the screening visit: Cough, shortness of breath, fever/chills, sore throat, nausea, vomiting, diarrhea, fatigue, body aches, headache
* Ability to give informed consent (administered in local language)
Exclusion Criteria
* Asymptomatic Covid-19 patients
* Pregnant or breastfeeding woman
* Current or recent use of the study drug
* Known allergy to study drug
* Current or planned participation in another interventional trial in next 10 days.
* Critical Covid-19 patients (ARDS) at the time of screening.
* Patients needing intubation, mechanical ventilation, or ICU care at screening
* Patients with prior cardiac disease including cardiac dysrhythmias, heart failure, ischemic heart disease or cardiomyopathies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT05889793
Study Brief:
Protocol Section:
NCT05889793